Search

New MSK research finds both acupuncture and massage can benefit those with cancer-related pain; investigates relapse after CAR T cell therapy for multiple-myeloma; and showcases the power of open-source science to develop medicines against COVID-19 and other pandemics.

… Monday, November 27, 2023 New research from Memorial Sloan Kettering Cancer Center (MSK) finds both acupuncture and massage can benefit those with cancer-related pain; investigates relapse after CAR T cell therapy for multiple-myeloma; and showcases the power of open-source science to develop medicines

Researchers have identified a specific group of microRNA molecules that are responsible for controlling genes that cause breast cancer metastasis.

… Wednesday, January 9, 2008 Researchers have identified a specific group of microRNA molecules that are responsible for controlling genes that cause breast cancer metastasis. The study, led by scientists at Memorial Sloan Kettering Cancer Center (MSKCC), appears in the January 10, 2008, issue of Nature

SKI researchers have learned how tiny droplets prevent a cancer-causing type of messenger RNA from being degraded in leukemia cells.

… Thursday, May 27, 2021 Cancer cells have many ways to protect themselves from the body’s natural defense systems. Recently, researchers in the Sloan Kettering Institute discovered a new one: Some cancer cells are able to form protective droplets called nuclear bodies around the genetic material that

MSK researchers have found mutations that arise in embryos can convey a risk of cancer that’s similar to what’s seen in people with inherited cancer mutations.

… Wednesday, January 5, 2022 The underlying genetic causes of cancer have traditionally been put into one of two categories: Tumors are caused either by somatic mutations, which arise by chance over the course of a person’s life, or by germline mutations, which are inherited at birth from a parent and

Learn more from Andrea Cercek about a new study showing that colorectal cancer rates are increasing in younger people.

… Tuesday, February 28, 2017 Summary MSK expert Andrea Cercek discusses findings from a new study showing rising colorectal cancer rates among people in their 20s and 30s. Though the overall incidence of colorectal cancer has been on the decline in the US for years, it is increasing among individuals in

Read about a new CAR T cell therapy now approved for marginal zone lymphoma (MZL).

… Friday, December 12, 2025 Marginal zone lymphoma is a slow-growing, rare form of  non-Hodgkin lymphoma that usually responds well to initial therapies. But in some patients, the disease keeps returning despite multiple treatments. Now the U.S. Food and Drug Administration (FDA) has approved a new therapy

Meet Jaap-Jan “J. J.” Boelens, who joined MSK Kids in 2018 as Chief of the Stem Cell Transplantation and Cell Therapy Service.

… Monday, October 7, 2019 Jaap-Jan “J. J.” Boelens joined MSK Kids in 2018 as Chief of the Stem Cell Transplantation and Cell Therapy Service. Some of our MSK Kids patients asked him the questions they were most curious about. You’re a new doctor here at MSK Kids. Where did you come from? — James, 4 I

Unlike the clinical management of other types of cancer, a multidisciplinary approach is not the established norm for treating skin cancer, resulting in significantly limited opportunities to individualize patient care.

… Thursday, June 14, 2018 Unlike the clinical management of other types of cancer, a multidisciplinary approach is not the established norm for treating skin cancer, resulting in significantly limited opportunities to individualize patient care. A recent study by our group, and set to be published in the

Memorial Sloan Kettering's new chief nurse Tracy Gosselin says she was taken by surprise when she was asked to consider MSK's top nursing job.

… Thursday, May 5, 2022 Tracy Gosselin says she was taken by surprise when she got the call asking her to consider applying for the top nursing job at Memorial Sloan Kettering Cancer Center (MSK).  “I laughed and said, ‘I can give you lots of names,’ ” she recalls. After careful thought and consultation

Memorial Sloan Kettering Cancer Center (MSK) announces the following awards and appointments.

… Thursday, February 29, 2024 Memorial Sloan Kettering Cancer Center (MSK) today announced the following awards and appointments: Yael David Awarded 2024 Alfred P. Sloan Research Fellowship Yael David Yael David, PhD ,  chemical biologist leading  The Yael David Lab  and   Associate Member of the  Chemical